Cargando…
Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab
BACKGROUND: Targeting drugs to their sites of action to overcome the systemic side effects associated with most antineoplastic agents is still a major challenge in pharmaceutical research. In this study, the monoclonal antibody, trastuzumab, was used as a targeting agent in nanoparticles carrying th...
Autores principales: | Yousefpour, Parisa, Atyabi, Fatemeh, Vasheghani-Farahani, Ebrahim, Movahedi, Ali-Akbar Mousavi, Dinarvand, Rassoul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181058/ https://www.ncbi.nlm.nih.gov/pubmed/21976974 http://dx.doi.org/10.2147/IJN.S21523 |
Ejemplares similares
-
Polyanionic carbohydrate doxorubicin–dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations
por: Yousefpour, Parisa, et al.
Publicado: (2011) -
Preparation and comparison of chitosan nanoparticles with different degrees of glutathione thiolation
por: Yousefpour, P., et al.
Publicado: (2011) -
Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cells
por: Talaei, Fatemeh, et al.
Publicado: (2011) -
Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study
por: Hosseinzadeh, Hosniyeh, et al.
Publicado: (2012) -
Enhanced Oral Delivery of Docetaxel Using Thiolated Chitosan Nanoparticles: Preparation, In Vitro and In Vivo Studies
por: Saremi, Shahrooz, et al.
Publicado: (2013)